Axsome Therapeutics Inc Capital Reinvestment Ratio

Latest as of September 2025: 0.06x

Axsome Therapeutics Inc capital reinvestment ratio. Axsome Therapeutics Inc (AXSM) has a Capital Reinvestment Ratio of 0.06x as of September 2025, meaning it reinvests 0% of its operating cash flow ($1.05 Million) in capital expenditures ($58.00K). See Axsome Therapeutics Inc (AXSM) free cash flow to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.06x

Capex / Operating Cash Flow

Operating Cash Flow

$1.05 Million

USD

Capital Expenditures

$58.00K

USD

Data as of

Sep 2025

Most recent filing

Axsome Therapeutics Inc Capital Reinvestment Ratio by Year (None–None)

Axsome Therapeutics Inc capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see AXSM cash flow metrics.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow